Yüksel Ürün

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031

Yüksel Ürün
May 31, 2024, 10:51 | Blog
Yüksel Ürün on CheckMate 901 trial
Yüksel Ürün shared a post on X: "CheckMate 901 trial: Abstract #4509 For lymph node-only mUC,…
May 30, 2024, 10:27 | Societies
Hatice Bölek: Thanks to ASCO and Conquer Cancer for supporting young researchers
Hatice Bölek, Medical Oncologist at Ankara University School of Medicine, shared on X: "Thanks to…
May 27, 2024, 08:36 | Societies
Giuseppe Banna: The Second International Urology Cancer Summit will take place in Portsmouth on September 27, 2024
Giuseppe Banna, Consultant Medical Oncologist at Portsmouth Hospitals University NHS Trust, recently shared a post…
May 25, 2024, 11:59 | Blog
Vivek Subbiah: ASCO 24 time to learn the latest and greatest in Tissue Agnostic Precision Medicine
Vivek Subbiah shared on X: “It's ASCO 24 time Mark your calendars to learn the latest…
May 20, 2024, 14:23 | Insight
Yüksel Ürün: Does oncologic treatment for very advanced disease improve survival?
Yüksel Ürün shared a post on X: “Does oncologic treatment for very advanced disease improve survival?…
May 18, 2024, 16:04 | Blog
Yüksel Ürün: Revolutionizing Cancer Care
Yüksel Ürün shared a post on X: "Revolutionizing Cancer Care A new machine learning-based immune profiling…
May 18, 2024, 10:20 | Insight
Yüksel Ürün: Top Advances of the Year in Perioperative Therapy for Lung Cancer
Yüksel Ürün shared on X: . "Top Advances of the Year: Perioperative Therapy for Lung…
May 16, 2024, 12:24 | Blog
Yüksel Ürün: Long-term weight loss effects of semaglutide
Yüksel Ürün shared on X/Twitter: ''Long-term weight loss effects of semaglutide. SELECT trial show semaglutide…
May 14, 2024, 13:15 | Insight
Yüksel Ürün: A study from Sweden on over 350,000 men
Yüksel Ürün shared on X: "A study from Sweden on over 350,000 men: .  α1-adrenoceptor…
May 13, 2024, 08:04 | Insight
Petros Grivas: We are getting ready for annual bladder cancer walk in Seattle Lake Sammamish
Petros Grivas, GU oncologist at Fred Hutchinson Cancer Center and Director of the University of Washington…
May 12, 2024, 07:40 | Insight
Yüksel Ürün: Excellent research on plasma Kidney Injury Molecule-1
Yüksel Ürün shared on X: "Congratulations to Wenxin Xu and the team for their excellent…
May 8, 2024, 10:53 | Blog
Yüksel Ürün: 2022 Global Cancer Report Raises Alarm
Yüksel Ürün shared a post on X/Twitter: "2022 Global Cancer Report Raises Alarm! High Disease…
May 2, 2024, 16:18 | Insight
Yüksel Ürün: New MASCC-ASCO standards to standardize quality survivorship care
Yüksel Ürün, Professor of Medicine at the Ankara University School of Medicine, shared a post…
Apr 30, 2024, 19:43 | Insight
Erman Akkus: Our new study Prostate Cancer and PARPi
Erman Akkus, Medicine Oncology and Internal Medicine Specialist at Ankara University, shared on X: “Our…
Apr 30, 2024, 13:58 | Blog
Yüksel Ürün: With great power comes great responsibility
Yüksel Ürün, Professor at Ankara University School of Medicine, recently shared on X: "How to…
Apr 27, 2024, 14:44 | Insight
Aruni Ghose: Our review delves into the progress across urological malignancies and discusses future directions in ADC development
Aruni Ghose, Internal Medicine Resident at Barts Health NHS Trust, shared a post on LinkedIn:…
Apr 27, 2024, 10:00 | Blog
Yüksel Ürün: How do experts agree on treating high-risk localized prostate cancer with clear evidence of T3 disease on MRI?
Yüksel Ürün, Doctorate Professor at the Faculty of Medicine, Ankara University, Turkey, shared on X/Twitter:…
Apr 27, 2024, 09:36 | Blog
Yüksel Ürün: The next step if a PSMA PET scan shows a positive bone lesion without a CT correlate in high-risk prostate cancer
Yüksel Ürün, Professor at the Faculty of Medicine, Ankara University, Turkey, shared on X/Twitter: "What…
Apr 26, 2024, 08:52 | Blog
Yuksel Urun: A brilliant perspective and a lesson-laden approach from Bernard Escudier, Gustave Roussy
Yuksel Urun, Professor in Department of Medical Oncology at Ankara University School of Medicine, shared…
Apr 26, 2024, 08:22 | Blog
Yuksel Urun: Europe emphasized program implementation for patient and organization support
Yuksel Urun, Professor in Department of Medical Oncology at Ankara University School of Medicine, shared…
Apr 23, 2024, 23:49 | Drugs
Yüksel Ürün: Updated 1st-line treatment in mRCC!
Yüksel Ürün, Doctorate Professor at the Faculty of Medicine, Ankara University, Turkey, shared a post…
Apr 21, 2024, 08:54 | Insight
Rana McKay wins the 2024 Christopher G. Wood Rising Star Award at IKCS Europe
Rana McKay won the 2024 Christopher G. Wood Rising Star Award at IKCS Europe, which…
Apr 14, 2024, 10:45 | Drugs
Final pre-spectified overall survival analysis of CLEAR, a phase III study - summarized by Yuksel Urun
Yuksel Urun, Professor in Department of Medical Oncology at Ankara University School of Medicine, shared…
Apr 14, 2024, 07:20 | Societies
Daniel Castellano: The ASCO24 football tournament is back again this year
Daniel Castellano, Medical Oncologist at University Hospital October 12, shared on X/Twitter: ''The most funky,…
Apr 7, 2024, 11:45 | Drugs
Yüksel Ürün: Adding immunotherapy to cabozantinib for mccRCC after 1st line immunotherapy showed no extra benefit in real-world data
Yüksel Ürün, Doctorate Professor at the Faculty of Medicine, Ankara University, Turkey, shared a post…
Apr 2, 2024, 21:45 | Insight
Yüksel Ürün: KEYNOTE-412 trial shows pembrolizumab + chemoradiotherapy doesn't significantly improve event-free survival in unselected advanced head and neck squamous cell carcinoma vs placebo
Apr 1, 2024, 13:09 | Insight
Yüksel Ürün: This research suggests ctDNA could revolutionize pre-surgical decision-making and treatment strategies, ensuring more personalized care
Yüksel Ürün, Medical Oncologist at Ankara University, shared a post on X/Twitter: "Circulating tumor DNA…
Mar 28, 2024, 03:11 | Drugs
Yüksel Ürün: US FDA approves mirvetuximab soravtansine-gynx for FRα+ platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer
Yüksel Ürün, Professor of Medical Oncology at Ankara University School of Medicine, shared a post…
Mar 20, 2024, 22:40 | Blog
Yüksel Ürün: Encouraging trend in survival for metastatic prostate cancer!
Yüksel Ürün, Professor of medicine in the Department of Medical Oncology of Ankara University School of…
Mar 18, 2024, 19:45 | Drugs
Yüksel Ürün: ASCO guideline says research is limited for cannabis for Cancer
Yüksel Ürün, Professor of medicine in the Department of Medical Oncology of Ankara University School of…
Mar 9, 2024, 12:51 | Insight
Yüksel Ürün: Important information for lung cancer patients taking TKIs
Yüksel Ürün, Professor of medicine in the Department of Medical Oncology of Ankara University School of…
Mar 4, 2024, 10:35 | Drugs
Yüksel Ürün: Topical diclofenac gel reduces painful hand-foot syndrome in patients on capecitabine
Yüksel Ürün, Professor of medicine in the Department of Medical Oncology of Ankara University School…
Feb 25, 2024, 16:11 | Insight
Aruni Ghose: Delighted to see our prospective blinded validation trial on the URO17 urinary bladder cancer biomarker published in BMC Urology by Springer Nature Group
Aruni Ghose, Focused Topic Network Member at European Cancer Organisation, shared a post on LinkedIn: ''Delighted…
Feb 13, 2024, 18:54 | Opinion
Yüksel Ürün: Pegfilgrastim in metastatic germ-cell tumor treatment with bleomycin shows no increased risk for lung toxicity
Yüksel Ürün, Professor of Medical Oncology at Ankara University, shared on X/Twitter: “Pegfilgrastim in metastatic germ-cell…
Jan 30, 2024, 11:13 | Positive
Yüksel Ürün: Being together with Emre Yekedüz on the 20th anniversary of ASCO GU is a source of happiness and pride
Yüksel Ürün, Professor of Medical Oncology at Ankara University, shared on X/Twitter: "Being together with…
Jan 28, 2024, 18:54 | Societies
10 posts from ASCO GU 2024 by Yüksel Ürün
Yüksel Ürün, Professor of Medical Oncology at Ankara University, has recapped ASCO GU highlights on…
Jan 21, 2024, 05:16 | Insight
Yüksel Ürün: ctDNA proves to be a valuable marker for guiding adjuvant chemotherapy decisions in CRC patients
Yüksel Ürün, Professor of Medical Oncology at AnkaraUniversity, shared the photo of Pashtoon Kasi on…
Jan 18, 2024, 16:08 | Insight
Yüksel Ürün: Exciting news for cancer patients and researchers alike!
Yüksel Ürün, Professor at the Department of Medical Oncology at the Ankara University School of…
Jan 17, 2024, 19:34 | Drugs
Yüksel Ürün: The U.S. FDA has approved pembrolizumab in combination with chemoradiotherapy for FIGO 2014 Stage III-IVA cervical cancer
Yüksel Ürün, Professor at the Department of Medical Oncology at the Ankara University School of…
Jan 12, 2024, 23:05 | Insight
Yüksel Ürün: Radiographic and Clinical PFS as Surrogates for OS in Prostate Cancer shows promise in accelerating trials!
Yüksel Ürün, Professor at the Department of Medical Oncology, Ankara University School of Medicine, recently…
Jan 12, 2024, 21:53 | Opinion
Yüksel Ürün: Exploring the next generation of antibody–drug conjugates
Yüksel Ürün, Professor at the Department of Medical Oncology, Ankara University School of Medicine, recently…
Jan 6, 2024, 23:03 | Insight
Yüksel Ürün: BEATcc Trial
Yüksel Ürün, Professor at the Department of Medical Oncology, Ankara University School of Medicine, recently…
Jan 3, 2024, 20:27 | Opinion
Yüksel Ürün: Improving Clinical Trials for a Healthier Tomorrow
Yüksel Ürün, Professor at the Department of Medical Oncology, Ankara University School of Medicine, recently…
Dec 30, 2023, 17:48 | Blog
Yüksel Ürün: A game-changer for cancer prevention strategies
Yüksel Ürün, Medical Oncologist at Ankara University, shared a post on X/Twitter: "UK biobank study:…
Dec 28, 2023, 17:11 | Insight
Yüksel Ürün: The crucial role of low-grade AEs in cancer treatment
Yüksel Ürün, Professor at the Department of Medical Oncology, Ankara University School of Medicine, recently…
Dec 20, 2023, 23:40 | Blog
Yüksel Ürün: Today is a day of mixed emotions for me
Yüksel Ürün, Professor at the Department of Medical Oncology, Ankara University School of Medicine, recently…
Dec 20, 2023, 11:19 | Blog
Yüksel Ürün: PARP inhibitors in treating prostate cancer
Yüksel Ürün, Medical Oncologist at Ankara University, shared on X/Twitter: “Thrilled to share our latest…
Dec 19, 2023, 18:52 | Insight
Yüksel Ürün: The final analysis of the IMvigor130
Yüksel Ürün, Professor at the Department of Medical Oncology, Ankara University School of Medicine, recently…
Dec 19, 2023, 09:13 | Blog
Yüksel Ürün: Congratulations to Tom Powles for being recognized as one of the top influencers in science for the year 2023 by Nature!
Yüksel Ürün, Professor at the Department of Medical Oncology, Ankara University School of Medicine, recently…
Dec 16, 2023, 11:36 | Blog
Yüksel Ürün: MRI alongside CT scans significantly improves treatment plans for colorectal liver metastases
Yüksel Ürün, Medical Oncologist at Ankara University, shared on X/Twitter: “MRI alongside CT scans significantly…
Dec 11, 2023, 18:34 | Insight
Yüksel Ürün: Mirvetuximab Soravtansine (MIRV) shows promise in platinum-resistant ovarian cancer
Yüksel Ürün, Medical Oncologist at Ankara University, shared on X/Twitter: ''Mirvetuximab Soravtansine (MIRV) shows promise…
Dec 10, 2023, 16:59 | Insight
Yüksel Ürün: MFS continues to be a reliable predictor for overall survival
Yüksel Ürün, Medical Oncologist at Ankara University, shared on X: “With better access to docetaxel…
Dec 7, 2023, 19:07 | Blog
Yüksel Ürün: New Study on Cancer Biomarkers!
Yüksel Ürün, Medical Oncologist at Ankara University, shared a post on X/Twitter: "New Study on…
Dec 6, 2023, 13:54 | Insight
Yüksel Ürün: The TALAPRO-2 trial shows a promising combo of talazoparib and enzalutamide for metastatic castration-resistant prostate cancer with HRR gene alterations
Yüksel Ürüna, Professor at Ankara University School of Medicine, shared on X/Twitter: "The TALAPRO-2 trial shows…
Dec 2, 2023, 15:23 | Blog
Yüksel Ürün: The ctDNA clearance during definitive SOC therapy is associated with improved outcome
Yüksel Ürün, Medical Oncologist at Ankara University, shared on X/Twitter: "A study shows combining circulating…
Nov 11, 2023, 17:36 | Blog
Yüksel Ürün: Just concluded an extraordinarily productive Leadership Development Program meeting
Yüksel Ürün, Medical Oncologist at Ankara University, shared on X/Twitter: "Just concluded an extraordinarily productive…
Oct 31, 2023, 04:25 | Dialogues
5min OncoDaily Updates with Chandler Park: Dr. Yüksel Urun on practice changing CheckMate 901 study for bladder cancer patients
[embed]https://www.youtube.com/watch?v=5qJ8T2SFHOA[/embed]
Oct 25, 2023, 18:50 | Blog
Emre Yekedüz: Our results including more than 20,000 patients were presented as a poster at ESMO23
Quoting Emre Yekedüz, Associate Professor of Medical Oncology at Ankara University, on X/Twitter: ''Our results…
Sep 27, 2023, 18:17 | Insight
Yüksel ÜRÜN: Our paper titled "Adjuvant Therapy for Renal Cell Carcinoma: A Systematic Review of Current Landscape and Future Directions" is now online.
Quoting Yüksel ÜRÜN, Professor at the Ankara University School of Medicine in Turkey, on X/Twitter:…
Jul 13, 2023, 19:32 | Stories
My heart is filled with gratitude for the simply perfect three days I spent at ASCO HQ for LDP - Yüksel Ürün
My heart is filled with gratitude for the simply perfect three days I spent at…
All: 260 Posts: 201 - 300
Special Coverage